As shown in Figure 7, K and L, while the CA12 inhibitor or anti–PD-1 antibodies alone could reduce tumor volumes and weights compared with control treatments, the combination of CA12 and PD-1 blockade exhibited much greater efficacy in terms of attenuating tumor growth in mice in vivo. This evidence concerns the gene PDCD1 and neoplasm.